Search research articles
Contact Us
Filters
Showing results (551-560 of 649) with videos related to
Page
of 65
Sort By:
The Review of Scientific Instruments
|
September 3, 2020
Doppler coherence imaging of scrape-off-layer impurity flows in the HL-2A tokamak
T Long, J S Allcock, L Nie, et al.
JAMA Cardiology
|
October 5, 2017
Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart Study
Ravi V Shah, Ashish S Yeri, Venkatesh L Murthy, et al.
Molecular Psychiatry
|
August 14, 1998
Large CAG/CTG repeats are associated with childhood-onset schizophrenia
C E Burgess, K Lindblad, E Sidransky, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 13, 2006
Acyclic, orally bioavailable ketone-based cathepsin K inhibitors
David G Barrett, John G Catalano, David N Deaton, et al.
Peerj
|
April 9, 2014
Is coral richness related to community resistance to and recovery from disturbance?
Stacy Y Zhang, Kelly E Speare, Zachary T Long, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 17, 2023
A population-based serological survey of <i>Vibrio cholerae</i> antibody titers in Ouest Department, Haiti in the year prior to the 2022 cholera outbreak
Christy H Clutter, Molly B Klarman, Youseline Cajusma, et al.
BMC Pulmonary Medicine
|
May 24, 2026
CT-adipose measures identify severe SARS-CoV-2 risk beyond traditional obesity metrics: a C4R cohort study
Nadine Al-Naamani, Pallavi Balte, Michael G S Shashaty, et al.
Journal of Medicinal Chemistry
|
January 23, 2004
Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k
Francis X Tavares, Virginia Boncek, David N Deaton, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 27, 2005
Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors
David G Barrett, John G Catalano, David N Deaton, et al.
Alimentary Pharmacology & Therapeutics
|
January 13, 2000
Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer
H V Mao, B V Lak, T Long, et al.
Page
of 65
Search research articles
Search
Showing results (551-560 of 649) with videos related to
Sort By:
Page
of 65
The Review of Scientific Instruments
|
September 3, 2020
Doppler coherence imaging of scrape-off-layer impurity flows in the HL-2A tokamak
T Long, J S Allcock, L Nie, et al.
JAMA Cardiology
|
October 5, 2017
Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart Study
Ravi V Shah, Ashish S Yeri, Venkatesh L Murthy, et al.
Molecular Psychiatry
|
August 14, 1998
Large CAG/CTG repeats are associated with childhood-onset schizophrenia
C E Burgess, K Lindblad, E Sidransky, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 13, 2006
Acyclic, orally bioavailable ketone-based cathepsin K inhibitors
David G Barrett, John G Catalano, David N Deaton, et al.
Peerj
|
April 9, 2014
Is coral richness related to community resistance to and recovery from disturbance?
Stacy Y Zhang, Kelly E Speare, Zachary T Long, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 17, 2023
A population-based serological survey of <i>Vibrio cholerae</i> antibody titers in Ouest Department, Haiti in the year prior to the 2022 cholera outbreak
Christy H Clutter, Molly B Klarman, Youseline Cajusma, et al.
BMC Pulmonary Medicine
|
May 24, 2026
CT-adipose measures identify severe SARS-CoV-2 risk beyond traditional obesity metrics: a C4R cohort study
Nadine Al-Naamani, Pallavi Balte, Michael G S Shashaty, et al.
Journal of Medicinal Chemistry
|
January 23, 2004
Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k
Francis X Tavares, Virginia Boncek, David N Deaton, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 27, 2005
Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors
David G Barrett, John G Catalano, David N Deaton, et al.
Alimentary Pharmacology & Therapeutics
|
January 13, 2000
Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer
H V Mao, B V Lak, T Long, et al.
Page
of 65